✦ LIBER ✦

Sa1318 Improvement of Liver Stiffness Measured by ARFI During Telaprevir-Based Triple Therapy for Chronic Hepatitis C

✍ Scribed by Kanata, Ryo; Goto, Takashi; Miura, Kouichi; Ohshima, Shigetoshi; Shibuya, Tomomi; Sato, Wataru; Kamada, Kentaro; Chiba, Mitsuru; Sakai, Toshitaka; Minami, Shinichiro; Sugimoto, Yuko; Fujiwara, Junichi; Ishioka, Mitsuaki; Ohnishi, Hirohide

Book ID: 122156893
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 94 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)60920-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1108 EFFICACY AND TOLERABILITY OF TELAP

P1108 EFFICACY AND TOLERABILITY OF TELAPREVIR-BASED TRIPLE THERAPY FOR ADVANCED FIBROSIS STAGE CHRONIC HEPATITIS C PATIENTS: RESULTS OF THE KYUSHU UNIVERSITY LIVER DISEASE STUDY GROUP

✍ Furusyo, N.; Ogawa, E.; Nakamuta, M.; Kajiwara, E.; Nomura, H.; Dohmen, K.; Taka 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Protease inhibitor-based triple therapy

Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

✍ Vincent Leroy; Lawrence Serfaty; Marc Bourlière; Jean-Pierre Bronowicki; Patrick 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB